Diagnostics
News and analysis on diagnostic technologies and applications.
William Blair Initiates Coverage of MDxHealth With Outperform Rating
A letter to investors noted the company's dedicated focus on prostate cancer diagnostics, which de-risks the firm's growth outlook and path to profitability.
The company's next-generation sequencing-based test detects more than 400 recurrent alterations that can identify 96 percent of bladder cancers.
Immunopeptidomics Firm ImmuneSpec Secures €1.2M in Seed Funding
The firm will use the funds to commercialize its mass spec-based immunopeptidomics platform, which it plans to apply to vaccine and drug development.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.
Thermo Fisher Scientific's IonTorrent Genexus platform can provide cancer panel results in about a day, but data on clinical impact of the fast turnaround has not yet been produced.